Yes, oral and genital chlamydia are treated with the same antibiotic. The CDC recommends doxycycline 100 mg taken twice daily for seven days regardless of where the infection is located. There is no separate treatment protocol for throat (pharyngeal) chlamydia versus genital chlamydia, though the two infections differ in how they’re detected, how they show up symptomatically, and how reliably the medication clears them.
The Standard Treatment for Both Sites
Doxycycline for seven days is the first-line treatment for chlamydia infections in adults and adolescents, whether the infection is in the throat, genitals, or rectum. If you can’t take doxycycline, azithromycin as a single one-gram dose is an alternative. A third option, levofloxacin taken once daily for seven days, is also available for people who need it.
Until recently, the single-dose azithromycin was used more commonly because of its convenience. The CDC shifted to recommending doxycycline as the preferred option because evidence suggests it’s more effective overall, particularly for infections outside the genitals. That seven-day course matters more for oral chlamydia, where a single dose may not clear the bacteria as reliably as it does at genital sites.
Why Oral Chlamydia Is Harder to Catch
The biggest practical difference between oral and genital chlamydia isn’t treatment. It’s diagnosis. Most commercially available chlamydia tests are FDA-cleared only for genital specimens: cervical swabs, urethral swabs, and urine samples. Testing throat swabs with these same methods has had limited evaluation, and some labs may not offer it as a routine option.
Culture-based testing and a technique called direct fluorescent antibody testing can be used on throat swabs, but these methods are less widely available than the standard urine or swab tests most clinics use. This means oral chlamydia often goes undetected simply because it isn’t tested for. If you’ve had oral sex with a partner who has chlamydia, you may need to specifically request a throat swab, and not every provider will have the testing infrastructure for it.
Symptoms at Each Site
Chlamydia is often called a “silent infection” because 50% to 70% of people with it never notice symptoms, regardless of where the infection is. When symptoms do appear, they typically show up between one week and three months after exposure.
Genital chlamydia, when symptomatic, can cause unusual discharge, burning during urination, or pain in the pelvic area for women and testicular area for men. Oral chlamydia is even less likely to produce noticeable symptoms. When it does, it may cause a persistent sore throat, redness in the back of the throat, or mild discomfort that’s easily mistaken for a cold or allergies. This overlap with common, harmless conditions is another reason oral infections fly under the radar.
What Happens If Either Goes Untreated
The consequences of untreated chlamydia are much better documented for genital infections. In women, untreated genital chlamydia can lead to pelvic inflammatory disease, which in turn can cause scarring in the fallopian tubes, ectopic pregnancy, chronic pelvic pain, and infertility. In men, it can cause painful inflammation in the tubes attached to the testicles, and in rare cases, fertility problems. Untreated chlamydia at any site also increases the risk of acquiring or transmitting HIV.
The long-term health consequences specific to untreated oral chlamydia are less well studied. The throat infection is primarily a concern as a transmission route: someone with pharyngeal chlamydia can pass the bacteria to a partner’s genitals during oral sex, perpetuating the cycle of infection even when the person with the throat infection feels perfectly fine.
Retesting After Treatment
Regardless of infection site, the CDC recommends retesting three months after treatment. This isn’t a “test of cure” to confirm the antibiotic worked (though it serves that purpose too). It’s primarily a screen for reinfection, which is common if a sexual partner wasn’t treated at the same time or if you’ve had a new exposure. Reinfection rates for chlamydia are high enough that this three-month retest is considered standard care for anyone who tests positive, whether the original infection was in the throat, genitals, or rectum.
If you’re being treated for chlamydia at one site, it’s worth discussing with your provider whether you should be tested at other sites as well. Having a genital infection doesn’t rule out a simultaneous oral or rectal infection, and the same antibiotic course will treat all sites at once if they’re caught together.